Asymptomatic Elevation of Amylase and Lipase After Olanzapine
Treatment

J 2016

Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment

USTOHAL, Libor; Michaela MAYEROVÁ; Barbora VALKOVÁ; Hana SEDLÁKOVÁ; Tomáš KAŠPÁREK et al.

Základní údaje

Originální název

Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment

Autoři

USTOHAL, Libor; Michaela MAYEROVÁ; Barbora VALKOVÁ; Hana SEDLÁKOVÁ a Tomáš KAŠPÁREK

Vydání

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2016, 0271-0749

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30104 Pharmacology and pharmacy

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.891

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14740/16:00090599

Organizační jednotka

Středoevropský technologický institut

Klíčová slova anglicky

ACUTE-PANCREATITIS

Štítky

EL OK, podil, rivok

Změněno: 30. 8. 2016 14:25, Mgr. Eva Špillingová

Anotace

V originále

Olanzapine, an atypical antipsychotic,has been considered one of the most efficient antipsychotic drugs, and it is the most frequently prescribed. It is categorized as a multiacting receptor targeted antipsychotic. The most significant adverse effects of olanzapine are metabolic: acute pancreatitis is one of the most serious adverse effects; fortunately, it does not occur very often. Koller et al1 found 51 cases,and at least 13 cases have been described more precisely. We present a case study of a young female patient with a very fast and high increase of amylase and lipase, who remained asymptomatic, immediately after olanzapine treatment.

Návaznosti

LQ1601, projekt VaV

Název: CEITEC 2020 (Akronym: CEITEC2020)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CEITEC 2020

Citovat

USTOHAL, Libor; Michaela MAYEROVÁ; Barbora VALKOVÁ; Hana SEDLÁKOVÁ a Tomáš KAŠPÁREK. Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2016, roč. 36, č. 2, s. 181-183. ISSN 0271-0749. Dostupné z: https://doi.org/10.1097/JCP.0000000000000460.

@article{1351896,
   author = {Ustohal, Libor and Mayerová, Michaela and Valková, Barbora and Sedláková, Hana and Kašpárek, Tomáš},
   article_location = {PHILADELPHIA},
   article_number = {2},
   doi = {https://doi.org/10.1097/JCP.0000000000000460},
   keywords = {ACUTE-PANCREATITIS},
   language = {eng},
   issn = {0271-0749},
   journal = {JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY},
   title = {Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment},
   url = {http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx},
   volume = {36},
   year = {2016}
}

TY  - JOUR
ID  - 1351896
AU  - Ustohal, Libor - Mayerová, Michaela - Valková, Barbora - Sedláková, Hana - Kašpárek, Tomáš
PY  - 2016
TI  - Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment
JF  - JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
VL  - 36
IS  - 2
SP  - 181-183
EP  - 181-183
PB  - LIPPINCOTT WILLIAMS & WILKINS
SN  - 02710749
KW  - ACUTE-PANCREATITIS
UR  - http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx
L2  - http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx
N2  - Olanzapine, an atypical antipsychotic,has been considered one of the most efficient antipsychotic drugs, and it is the most frequently prescribed. It is categorized as a multiacting receptor targeted antipsychotic. The most significant adverse effects of olanzapine are metabolic: acute pancreatitis is one of the most serious adverse effects; fortunately, it does not occur very often. Koller et al1 found 51 cases,and at least 13 cases have been described more precisely. We present a case study of a young female patient with a very fast and high increase of amylase and lipase, who remained asymptomatic, immediately after olanzapine treatment.
ER  -

USTOHAL, Libor; Michaela MAYEROVÁ; Barbora VALKOVÁ; Hana SEDLÁKOVÁ a Tomáš KAŠPÁREK. Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment. \textit{JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY}. PHILADELPHIA: LIPPINCOTT WILLIAMS \&{} WILKINS, 2016, roč.~36, č.~2, s.~181-183. ISSN~0271-0749. Dostupné z: https://doi.org/10.1097/JCP.0000000000000460.

Přehled o publikaci